Among US adults with chronic conditions, co-use of marijuana and opioids was associated with nearly double the odds of major depression compared to using neither substance, exceeding the risk of either substance alone.
Primary care physicians, pain management specialists, psychiatrists, patients with chronic conditions, and public health researchers.
What the researchers found
Co-use of marijuana and opioids had the strongest association with major depressive disorder (AOR=1.92, 95% CI=1.45-2.50), followed by marijuana only (AOR=1.72) and opioid only (AOR=1.44), compared to no use of either substance — with 20.8% of co-users meeting MDD criteria.
Why it matters
People with chronic conditions often use opioids for pain and may add cannabis — this study reveals that combining them carries the highest depression risk, which clinicians should monitor.
The numbers in context
N=35,585; 8.5% co-use; MDD rates: co-use 20.8%, marijuana only 18.4%, opioid only 9.3%, neither 5.6%; adjusted ORs: co-use 1.92, marijuana 1.72, opioid 1.44; all significant
How the study worked
Cross-sectional analysis of 2022 National Survey of Drug Use and Health data from 35,585 US adults with chronic conditions, using Rao-Scott chi-square tests and multivariable logistic regression adjusting for demographics, behavioral, clinical, and social factors.
What this study cannot tell us
Cross-sectional design cannot establish causality; self-reported substance use; past-year timeframe may miss temporal relationships; opioid use includes both prescribed and non-prescribed; marijuana use may be for self-medication of existing depression.
How to read the evidence
Large nationally representative sample with comprehensive statistical adjustments, but cross-sectional design and self-report measures limit causal conclusions.
When this study was published
Published 2026; uses 2022 NSDUH data.
The bigger picture
As cannabis legalization expands and more chronic pain patients consider adding cannabis to opioid regimens, understanding the compounding mental health risks of co-use is critical for informed clinical decision-making.
Questions still open
- Does co-use cause depression or do depressed individuals self-medicate with both substances? Would treating depression reduce co-use? Does the sequence of initiation (opioids first vs. cannabis first) affect risk?
Common questions
Does using marijuana and opioids together increase depression risk?
Is marijuana alone linked to depression in people with chronic conditions?
Read the original research
Association of Combined Marijuana and Opioid Use with Major Depressive Disorder Among Adults with Chronic Conditions in the United States.
Substance use : research and treatment, 20, 29768357261423812
Citation
Graham, Tiffany; Wiener, R Constance; Mitra, Sophie; Wang, Hao; Shen, Chan; Pedaprolu, Laskhmi; Sambamoorthi, Usha. (2026). Association of Combined Marijuana and Opioid Use with Major Depressive Disorder Among Adults with Chronic Conditions in the United States.. Substance use : research and treatment, 20, 29768357261423812. https://doi.org/10.1177/29768357261423812
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk